Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease.
Nat Commun
; 7: 10759, 2016 Feb 19.
Article
en En
| MEDLINE
| ID: mdl-26892305
ABSTRACT
Owing to their specificity and high-affinity binding, monoclonal antibodies have potential as positron emission tomography (PET) radioligands and are currently used to image various targets in peripheral organs. However, in the central nervous system, antibody uptake is limited by the blood-brain barrier (BBB). Here we present a PET ligand to be used for diagnosis and evaluation of treatment effects in Alzheimer's disease. The amyloid ß (Aß) antibody mAb158 is radiolabelled and conjugated to a transferrin receptor antibody to enable receptor-mediated transcytosis across the BBB. PET imaging of two different mouse models with Aß pathology clearly visualize Aß in the brain. The PET signal increases with age and correlates closely with brain Aß levels. Thus, we demonstrate that antibody-based PET ligands can be successfully used for brain imaging.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Encéfalo
/
Péptidos beta-Amiloides
/
Tomografía de Emisión de Positrones
/
Enfermedad de Alzheimer
Tipo de estudio:
Diagnostic_studies
/
Evaluation_studies
/
Prognostic_studies
Límite:
Animals
/
Humans
/
Male
Idioma:
En
Revista:
Nat Commun
Asunto de la revista:
BIOLOGIA
/
CIENCIA
Año:
2016
Tipo del documento:
Article
País de afiliación:
Suecia